{rfName}
Gu

Indexed in

License and use

Icono OpenAccess

Citations

6

Altmetrics

Grant support

This paper is part of a Supplement that was financially supported by the ERA. The topic of this paper was also presented at the 61st ERA Congress, Stockholm & Virtual, May 23-26, 2024.

Analysis of institutional authors

Ortiz, AlbertoAuthorFernandez-Fernandez, BeatrizAuthor

Share

December 2, 2024
Publications
>
Article
Sí

Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?

Publicated to:Clinical Kidney Journal. 17 36-50 - 2024-11-22 17(), DOI: 10.1093/ckj/sfae278

Authors: Theodorakopoulou, Marieta; Ortiz, Alberto; Fernandez-Fernandez, Beatriz; Kanbay, Mehmet; Minutolo, Roberto; Sarafidis, Pantelis A

Affiliations

Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol 1, Thessaloniki, Greece - Author
Koc Univ, Sch Med, Dept Nephrol, Istanbul, Turkiye - Author
UAM, IIS, Fdn Jimenez Diaz, Dept Nephrol & Hypertens, Madrid, Spain - Author
Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Nephrol Unit, Naples, Italy - Author

Abstract

Until recently, major bodies producing guidelines for the management of hypertension in patients with chronic kidney disease (CKD) disagreed in some key issues. In June 2023, the European Society of Hypertension (ESH) published the new 2023 ESH Guidelines for the management of arterial hypertension a document that was endorsed by the European Renal Association. Several novel recommendations relevant to the management of hypertension in patients with CKD appeared in these guidelines, which have been updated to reflect the latest evidence-based practices in managing hypertension in CKD patients. Most of these are in general agreement with the previous 2021 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines-some reflect different emphasis on some topics (i.e. detailed algorithms on antihypertensive agent use) while others reflect evolution of important evidence in recent years. The aim of the present review is to summarize and comment on key points and main areas of focus in patients with CKD, as well as to compare and highlight the main differences with the 2021 KDIGO Guidelines for the management of blood pressure in CKD.

Keywords

AlbuminuriaArterial-hypertensioBlood pressureBlood-pressure controlCardiovascular outcomesChronic kidney diseaseChronic kidney-diseaseClinical-practiceDiabetic-nephropathyGlucose cotransporter-2 inhibitorsGuidelinesHypertensioHypertensionMineralocorticoid receptor antagonistsResistant hypertensionStage renal-disease

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Clinical Kidney Journal due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position 18/126, thus managing to position itself as a Q1 (Primer Cuartil), in the category Urology & Nephrology.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-07-16:

  • WoS: 1
  • Scopus: 1

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-16:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 46.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 43 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 0.25.
  • The number of mentions on the social network X (formerly Twitter): 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Greece; Italy; Turkey.